ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.01
0.00%
US Tech 100
19,009.20
0.53%
S&P 500
5,614.56
-2.70%
US Dollar vs CAD
1.4396
-0.24%
Bitcoin
81,743.10
4.17%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Pliant Therapeutics Inc (PLRX) Share Price

Pliant Therapeutics Inc

Pliant Therapeutics Inc (PLRX)

NASDAQ
1.43
-0.19
(-11.73%)
Closed March 10 3:00PM
Delayed by 15 minutes
1.5801
0.1501
( 10.50% )
Pre Market: 7:08AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
1.5801
Bid
1.58
Ask
1.61
Volume
170,364
0.00 Day's Range 0.00
1.26 52 Week Range 16.52
Market Cap
96.155M
Previous Close
1.43
Open
-
Last Trade
553
@
1.5801
(formt)
Last Trade Time
07:08:56
Financial Volume
-
VWAP
-
Average Volume (3m)
2,500,035
Shares Outstanding
60,853,623
Dividend Yield
-
PE Ratio
-0.54
Earnings Per Share (EPS)
-2.65
Revenue
1.58M
Net Profit
-161.34M

About Pliant Therapeutics Inc

Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis. Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
pliantrx.com.
Headquarters
Dover, Delaware, USA
Founded
-
Pliant Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PLRX. The last closing price for Pliant Therapeutics was US$1.43. Over the last year, Pliant Therapeutics shares have traded in a share price range of US$ 1.26 to US$ 16.52.

Pliant Therapeutics currently has 60,853,623 shares outstanding. The market capitalization of Pliant Therapeutics is US$87.02 million. Pliant Therapeutics has a price to earnings ratio (PE ratio) of -0.54.

Ask ADVFN Intelligence (AI)

PLRX Latest News

More News

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
March 03 2025
PLRX (-11.73%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
March 03 2025
PLRX (-11.73%)

Form 8-K - Current report
Edgar (US Regulatory)
February 13 2025
PLRX (-11.73%)

Form 8-K - Current report
Edgar (US Regulatory)
February 10 2025
PLRX (-11.73%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
January 27 2025
PLRX (-11.73%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
January 27 2025
PLRX (-11.73%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.190113.67625899281.391.791.2642327591.46511991CS
4-1.4499-47.85148514853.033.781.2647926012.35211954CS
12-12.1199-88.466423357713.7151.2625000354.03600383CS
26-11.4399-87.864055299513.0216.11.2613579525.75130554CS
52-14.0499-89.890595009615.6316.521.269072597.63946185CS
156-7.3199-82.24606741578.936.641.2680166115.90775127CS
260-20.9199-92.977333333322.543.921.2654928016.6532315CS

PLRX - Frequently Asked Questions (FAQ)

What is the current Pliant Therapeutics share price?
The current share price of Pliant Therapeutics is US$ 1.5801
How many Pliant Therapeutics shares are in issue?
Pliant Therapeutics has 60,853,623 shares in issue
What is the market cap of Pliant Therapeutics?
The market capitalisation of Pliant Therapeutics is USD 87.02M
What is the 1 year trading range for Pliant Therapeutics share price?
Pliant Therapeutics has traded in the range of US$ 1.26 to US$ 16.52 during the past year
What is the PE ratio of Pliant Therapeutics?
The price to earnings ratio of Pliant Therapeutics is -0.54
What is the cash to sales ratio of Pliant Therapeutics?
The cash to sales ratio of Pliant Therapeutics is 55
What is the reporting currency for Pliant Therapeutics?
Pliant Therapeutics reports financial results in USD
What is the latest annual turnover for Pliant Therapeutics?
The latest annual turnover of Pliant Therapeutics is USD 1.58M
What is the latest annual profit for Pliant Therapeutics?
The latest annual profit of Pliant Therapeutics is USD -161.34M
What is the registered address of Pliant Therapeutics?
The registered address for Pliant Therapeutics is 850 NEW BURTON ROAD SUITE 201, DOVER, DELAWARE, 19904
What is the Pliant Therapeutics website address?
The website address for Pliant Therapeutics is pliantrx.com.
Which industry sector does Pliant Therapeutics operate in?
Pliant Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AWHAspira Womans Health Inc
US$ 0.365
(84.34%)
88.05M
TSVT2seventy bio Inc
US$ 4.93
(76.07%)
2.11M
CUTRCutera Inc
US$ 0.2061
(60.39%)
50.72M
SNOASonoma Pharmaceuticals Inc
US$ 4.33
(55.20%)
21.57M
SYRSSyros Pharmaceuticals Inc
US$ 0.1364
(48.91%)
19.17M
MBXMBX Biosciences Inc
US$ 5.01
(-44.21%)
2
ARVNArvinas Inc
US$ 9.99
(-43.11%)
488.12k
JANXJanux Therapeutics Inc
US$ 20.05
(-33.65%)
41
XAGELongevity Health Holdings Inc
 0.2411
(-24.66%)
908.85k
SVRASavara Inc
US$ 2.01
(-24.44%)
5
AWHAspira Womans Health Inc
US$ 0.365
(84.34%)
88.05M
CUTRCutera Inc
US$ 0.2061
(60.39%)
50.72M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7.73
(4.74%)
30.22M
SNOASonoma Pharmaceuticals Inc
US$ 4.33
(55.20%)
21.57M
SYRSSyros Pharmaceuticals Inc
US$ 0.1364
(48.91%)
19.17M

PLRX Discussion

View Posts
makinezmoney makinezmoney 1 week ago
$PLRX: Great Dip.............. wanna get it in soon


Now at $2.60


Got a bid in at $1.10 to see if it fills..................... 50k shares ............. FILL ME baby


GO $PLRX
👍️0
TrendTrade2016 TrendTrade2016 4 weeks ago
PLRX FRESH BIO BEAST
👍️0
Invest-in-America Invest-in-America 1 month ago
PLRX: Evidently, POSTING about THIS wildly-volatile stock is permitted only over on iHub's ORION's Board.
👍️0
stockprofitter stockprofitter 3 months ago
New 52wk highs coming soon
👍️0

Your Recent History

NASDAQ
PLRX
Pliant Therapeutics
TG
A28R16
Csg
TG
XOQB
Samvardhana Motherson Au
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads